1. WhippleGH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp1907;18:382.

2. HendrixJP, Black‐SchafferB, et al.Whipple's intestinal lipodystrophy; report of four cases and discussion of possible pathogenic factors. Arch Intern Med1950;85:91. CrossRef

3. UptonAC. Histochemical investigation of the mesenchymal lesions in Whipple's disease. Am J Clin Pathol1952;22:755.

4. SierackiJC, FineG. Whipple's disease; observations on systemic involvement. II. Gross and histologic observations. Arch Pathol1959;67:81.

5. DavisTDJr, McBeeJW, BorlandJLJr, et al.The effect of antibiotic and steroid therapy in Whipple's disease. Gastroenterology1985;88:1867.

6. WilsonKH, BlitchingtonR, FrothinghamR, et al.Phylogeny of the Whipple's‐disease‐ associated bacterium. Lancet1991;338:474. CrossRef

7. MaiwaldM, DittonHJ, von HerbayA, et al.Reassessment of the phylogenetic position of the bacterium associated with Whipple's disease and determination of the 16S‐23S ribosomal intergenic spacer sequence. Int J Syst Bacteriol1996;46:1078. CrossRef

8. KeitaAK, BasseneH, TallA, et al.Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis2011;5:e1403. CrossRef

9. RaoultD, FenollarF, RolainJM, et al.Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis2010;16:776. CrossRef

10. FenollarF, MediannikovO, SocolovschiC, et al.Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis2010;51:515. CrossRef

11. Black‐SchafferB. The tinctoral demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol Med1949;72:225. CrossRef

12. FenollarF, PuéchalX, RaoultD. Whipple's disease. N Engl J Med2007;356:55. CrossRef

13. DesnuesB, Al MoussawiK, FenollarF. New insights into Whipple's disease and Tropheryma whipplei infections. Microbes Infect2010;12:1102. CrossRef

14. PuéchalX. Whipple's disease. Ann Rheum Dis2013;72:797. CrossRef

15. BiagiF, TrottaL, CorazzaGR. Whipple's disease. Intern Emerg Med2012;7:S209. CrossRef

16. EnzingerFM, HelwigEB. Whipple's disease: a review of the literature and report of 15 patients. Virchows Arch A Pathol Anat Histopathol1963;336:238. CrossRef

17. MikscheLW, BlümckeS, FritscheD, et al.Whipple's disease: etiopathogenesis, treatment, diagnosis, and clinical course. Case report and review of the world literature. Hepatogastroenterol (Stuttg)1974;21:307.

18. MaizelH, RuffinJM, DobbinsWO3rd.Whipple's disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine (Baltimore)1993;72:343. CrossRef

19. GrossJB, WollaegerEE, SauerWG, et al.Whipple's disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology1959;36:65.

20. DykmanDD, CuccheriniBA, FussIJ, et al.Whipple's disease in a father‐daughter pair. Dig Dis Sci1999;44:2542. CrossRef

21. Schöniger‐HekeleM, PetermannD, WeberB, et al.Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol2007;73:2033. CrossRef

22. FenollarF, LaouiraS, LepidiH, et al.Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first‐line screening. Clin Infect Dis2008;47:659. CrossRef

23. FenollarF, TraniM, DavoustB, et al.Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis2008;197:880. CrossRef

24. FenollarF, KeitaAK, BuffetS, et al.Intrafamilial circulation of Tropheryma whipplei, France. Emerg Infect Dis2012;18:949. CrossRef

25. DobbinsWO3rd. HLA antigens in Whipple's disease. Arthritis Rheum1987;30:102. CrossRef

26. LagierJC, FenollarF, LepidiH, et al.Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother2011;66:1188. CrossRef

27. MoosV, SchmidtC, GeelhaarA, et al.Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology2010;138:210. CrossRef

28. BentleySD, MaiwaldM, MurphyLD, et al.Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet2003;361:637. CrossRef

29. RaoultD, OgataH, AudicS, et al.Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome. Genome Res2003;13:1800.

30. RenestoP, CrapouletN, OgataH, et al.Genome‐ based design of a cell‐free culture medium for Tropheryma whipplei. Lancet2003;362:447. CrossRef

31. MarthT, KleenN, StallmachA, et al.Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology2002;123:1468. CrossRef

32. MarthT, NeurathM, CuccheriniBA, et al.Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology1997;113:442. CrossRef

33. DesnuesB, RaoultD, MegeJL. IL‐16 is critical for Tropheryma whipplei replication in Whipple's disease. J Immunol2005;175:4575. CrossRef

34. GhigoE, BarryAO, PretatL, et al.IL‐16 promotesT. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS ONE2010;5:e13561. CrossRef

35. DesnuesB, IhrigM, RaoultD, et al.Whipple's disease: a macrophage disease. Clin Vaccine Immunol2006;13:170. CrossRef

36. DrancourtM, RaoultD, LépidiH, et al.Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann Intern Med2003;139:1046. CrossRef

37. DearmentMC, WoodwardTA, MenkeDM, et al.Whipple's disease with destructive arthritis, abdominal lymphadenopathy, and central nervous system involvement. J Rheumatol2003;30:1347.

38. TranHA. Reversible hypothyroidism and Whipple's disease. BMC Endocr Disord2006;6:3. CrossRef

39. ArnoldCA, MoreiraRK, Lam‐HimlinD, et al.Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol2012;36:1066. CrossRef

40. PuéchalX. Whipple disease and arthritis. Curr Opin Rheumatol2001;13:74. CrossRef

41. LouisED, LynchT, KaufmannP, et al.Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol1996;40:561. CrossRef

42. GerardA, Sarrot‐ReynauldF, LiozonE, et al.Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore)2002;81:443. CrossRef

43. McAllisterHAJr, FenoglioJJJr. Cardiac involvement in Whipple's disease. Circulation1975;52:152. CrossRef

44. GublerJG, KusterM, DutlyF, et al.Whipple endocarditis without overt gastrointestinal disease: report of four cases. Ann Intern Med1999;131:112. CrossRef

45. CraneS, SchlippertW. Duodenoscopic findings in Whipple's disease. Gastrointest Endosc1978;24:248. CrossRef

46. GeboesK, EctorsN, HeidbuchelH, et al.Whipple's disease: endoscopic aspects before and after therapy. Gastrointest Endosc1990;36:247. CrossRef

47. Dinis SilvaJ, FernandesV, AlvesMC, et al.Diagnostic ileoscopy assisting in the diagnosis of Whipple's disease. Endoscopy2013;45(S2):E59. CrossRef

48. NeumannH, NeufertC, ViethM, et al.High‐definition endoscopy with i scan enables diagnosis of characteristic mucosal lesions in Whipple's disease. Endoscopy2012;44(S2):E217. CrossRef

49. DolakW, LeitnerJ, MareschJ, et al.In vivo identification by confocal laser endoscopy of foamy macrophages associated with Whipple's disease. Endoscopy2010;42(S2):E310. CrossRef

50. Fritscher‐RavensA, SwainCP, von HerbayA. Refractory Whipple's disease with anaemia: first lessons from capsule endoscopy. Endoscopy2004;36:659. CrossRef

51. DzirloL, BlahaB, MüllerC, et al.Capsule endoscopic appearance of the small intestinal mucosa in Whipple's disease and the changes that occur during antibiotic therapy. Endoscopy2007;39(S1):E207. CrossRef

52. FenollarF, RaoultD. Molecular techniques in Whipple's disease. Expert Rev Mol Diagn2001;1:299. CrossRef

53. DobbinsWOIII. Whipple's Disease. Springfield Illinois: Charles C Thomas Ltd; 1987.

54. RaoultD, La ScolaB, LecocqP, et al.Culture and immunological detection of Tropheryma whipplei from the duodenum of a patient with Whipple disease. JAMA2001;285:1039. CrossRef

55. BaisdenBL, LepidiH, RaoultD, et al.Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin‐embedded tissue. Am J Clin Pathol2002;118:742. CrossRef

56. DumlerJS, BaisdenBL, YardleyJH, et al.Immunodetection of Tropheryma whipplei in intestinal tissues from Dr. Whipple's 1907 patient. N Engl J Med2003;348:1411. CrossRef

57. OlmosM, SmecuolE, MauriñoE, et al.Decision analysis: an aid to the diagnosis of Whipple's disease. Aliment Pharmacol Ther2006;23:833. CrossRef

58. FeurleGE, JungaNS, MarthT. Efficacay of ceftriaxone or meropenam asinitial therapies in Whipples disease. Gastroenterology2010;138:478. CrossRef

59. GillinJS, UrmacherC, WestR, et al.Disseminated Mycobacterium avium‐intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology1983;85:1187.

60. RothRI, OwenRL, KerenDF, et al.Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS).Histological and clinical comparison with Whipple's disease. Dig Dis Sci1985;30:497. CrossRef

61. FlemingJL, WiesnerRH, ShorterRG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc1988;63:539. CrossRef

62. von HerbayA, OttoHF. Whipple's disease: a report of 22 patients. Klin Wochenschr1988;66:533. CrossRef

63. BaiJC, CrosettiEE, MauriñoEC, et al.Short‐term antibiotic treatment in Whipple's disease. J Clin Gastroenterol1991;13:303. CrossRef

64. GeboesK, EctorsN, HeidbuchelH, et al.Whipple's disease: the value of upper gastrointestinal endoscopy for the diagnosis and follow‐up. Acta Gastroenterol Belg1992;55:209.

65. PaulleyJW. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology1952;22:128.

66. CannonWR. Whipple's disease, genomics, and drug therapy. Lancet2003;361:1916. CrossRef

67. KeinathRD, MerrellDE, VlietstraR, et al.Antibiotic treatment and relapse in Whipple's disease. Long‐term follow‐up of 88 patients. Gastroenterology1985;88:1867.

68. KnoxDL, BaylessTM, PittmanFE. Neurologic disease in patients with treated Whipple's disease. Medicine (Baltimore)1976;55:467.

69. FeurleGE, VolkB, WaldherrR. Cerebral Whipple's disease with negative jejunal histology. N Engl J Med1979;300:907. CrossRef

70. SearsCL, CosgroveSE. IV or not IV? Just one of the antibiotic questions in Whipple's disease. Gastroenterology2010;138:422. CrossRef

71. MoosV, FeurleGE, SchinnerlingK, et al.Immunopathology of immune reconstitutioninflammatory syndrome in Whipple's disease. J Immunol2013;190:2354. CrossRef

72. SchneiderT, StallmachA, von HerbayA, et al.Treatment of Refractory Whipple Disease withInterferon‐γ. Ann Intern Med1998;129:875. CrossRef

73. BoothCC. The first descrition of Tropical Sprue (William Hillary). Gut1964;5:45. CrossRef

74. RamakrishnaBS. Tropical sprue: a riddle wrapped in a mystery inside an enigma. Indian J Med Res2013;137:12.

75. LimML. A perspective on tropical sprue. Curr Gastroenterol Rep2001;3:322. CrossRef

76. AyreyF. Outbreaks of sprue during the Burma Campaign. Trans R Soc Trop Med Hyg1947–1948;41:377. CrossRef

77. MathanVI, IgnatiusM, BakerSJ. A household epidemic of tropical sprue. Gut1966;7:490. CrossRef

78. JonesTC, DeanAG, ParkerGW. Seasonal gastroenteritis and malabsorption at an American military base in the Philippines. II. Malabsorption following the acute illness. Am J Epidemiol1972;95:128.

79. KlipsteinFA. Tropical sprue in travelers and expatriates living abroad. Gastroenterology1981;80:590.

80. TrierJS, DonnellySM. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15‐1990. A 78‐year‐old woman from the Dominican Republic with chronic diarrhea. N Engl J Med1990;322:1067. CrossRef

81. GorbachSL, MitraR, JacobsB, et al.Bacterial contamination of the upper small bowel in tropical sprue. Lancet1969;1:74. CrossRef

82. KlipsteinFA, HoldemanLV, CorcinoJJ, et al.Enterotoxigenic intestinal bacteria in tropical sprue. Ann Intern Med1973;79:632. CrossRef

83. TomkinsAM, DrasarBS, JamesWP. Bacterial colonisation of jejunal mucosa in acute tropical sprue. Lancet1975;1:59. CrossRef

84. CookGC. Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet1984;1:721. CrossRef

85. RossIN, MathanVI. Immunological changes in tropical sprue. Q J Med1981;50:435.

86. TiruppathiC, BalasubramanianKA, HillPG, et al.Faecal free fatty acids in tropical sprue and their possible role in the production of diarrhoea by inhibition of ATPases. Gut1983;24:300. CrossRef

87. GlynnJ. Tropical sprue–its aetiology and pathogenesis. J R Soc Med1986;79:599.

88. MalikAK, MehtaSK, ChandrashekharY, et al.Quantitation of immunoglobulin‐containing cells in the jejunal lamina propria in tropical sprue. J Clin Gastroenterol1992;14:163. CrossRef

89. BathejaMJ, LeightonJ, AzuetaA, et al.The face of tropical sprue in 2010. Case Rep Gastroenterol2010;4:168. CrossRef

90. GersonCD, KentTH, SahaJR, et al.Recovery of small‐intestinal structure and function after residence in the tropics. II. Studies in Indians and Pakistanis living in New York City. Ann Intern Med1971;75:41. CrossRef

91. TawilSC, BrandtLJ, BernsteinLH. Scalloping of the valvulae conniventes and mosaic mucosa in tropical sprue. Gastrointest Endosc1991;37:365. CrossRef

92. ShahVH, RotterdamH, KotlerDP, et al.All that scallops is not celiac disease. Gastrointest Endosc2000;51:717. CrossRef

93. SchenkEA, SamloffIM, KlipsteinFA. Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. Am J Pathol1965;47:765.

94. BrunserO, EidelmanS, KlipsteinFA. Intestinal morphology of rural Haitians. A comparison between overt tropical sprue and asymptomatic subjects. Gastroenterology1970;58:655.

95. GuerraR, WhebyMS, BaylessTM. Long‐term antibiotic therapy in tropical sprue. Ann Intern Med1965;63:619. CrossRef

96. SheehyTW, BaggsB, Perez‐SantiagoE, et al.Prognosis of tropical sprue.A study of theeffect of folic acid on the intestinal aspects of acute and chronic sprue. Ann Intern Med1962;57:892. CrossRef

97. RicklesFR, KlipsteinFA, TomasiniJ, et al.Long‐term follow‐up of antibiotic‐treated tropical sprue. Ann Intern Med1972;76:203. CrossRef

98. ColeST, BarrellBG. Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp1998;217:160, discussion 172‐7. CrossRef

99. MinnikinDE, et al.The methyl‐branched fortifications of Mycobacterium tuberculosis. Chem Biol2002;9:545. CrossRef

100. HoffmannC, et al.Disclosure of the mycobacterial outer membrane: cryo‐electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A2008;105:3963. CrossRef

101. ChandraN, KumarD, RaoK. Systems biology of tuberculosis. Tuberculosis (Edinb)2011;91:487. CrossRef

102. Ortalo‐MagneA, et al.Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology1995;141(Pt 7):1609. CrossRef

103. (WHO), W.H.O., Global tuberculosis report 2012, 2012, WHO Press: Geneva, Switzerland. 1.

104. KeaneJ, et al.Tuberculosis associated with infliximab, a tumor necrosis factor alpha‐ neutralizing agent. N Engl J Med2001;345:1098. CrossRef

105. KwanCK, ErnstJD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev2011;24:351. CrossRef

106. CegielskiJP, ArabL, Cornoni‐HuntleyJ. Nutritional risk factors for tuberculosis among adults in the United States, 1971‐1992. Am J Epidemiol2012;176:409. CrossRef

107. SinclairD, et al.Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev2011;9(11):CD006086.

108. TanKK, ChenK, SimR. The spectrum of abdominal tuberculosis in a developed country: a single institution's experience over 7 years. J Gastrointest Surg2009;13:142. CrossRef

109. MamoJP, BrijSO, EnochDA. Abdominal tuberculosis: a retrospective review of cases presenting to a UK district hospital. QJM2013;106:347. CrossRef

110. JakubowskiA, ElwoodRK, EnarsonDA. Active abdominal tuberculosis in Canada in 1970‐81. CMAJ1987;137:897.

111. ZumlaA, et al.Tuberculosis. N Engl J Med2013;368:745. CrossRef

112. PetoHM, et al.Epidemiology of extrapulmonary tuberculosis in the United States, 1993‐2006. Clin Infect Dis2009;49:1350. CrossRef

113. Garcia‐RodriguezJF, et al.Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin2011;29:502. CrossRef

114. ShaferRW, et al.Extrapulmonary tuberculosis in patients with human immunodeficiencyvirus infection. Medicine (Baltimore)1991;70:384. CrossRef

115. LeedsIL, et al.Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis2012;55:75. CrossRef

116. SinghSB, et al.Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science2006;313:1438. CrossRef

117. GanH, et al.Mycobacterium tuberculosis blocks crosslinking of annexin‐1 and apoptoticenvelope formation on infected macrophages to maintain virulence. Nat Immunol2008;9:1189. CrossRef

118. ClemensDL, HorwitzMA. Characterization of the Mycobacterium tuberculosisphagosome and evidence that phagosomal maturation is inhibited. J Exp Med1995;181:257. CrossRef

119. PhilipsJA, ErnstJD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol2012;7:353. CrossRef

120. MacMickingJD, TaylorGA, McKinneyJD. Immune control of tuberculosis by IFN‐gamma‐inducible LRG‐47. Science2003;302:654. CrossRef

121. van der WelN, et al.M. tuberculosis and M. leprae translocate from the phagolysosome tothe cytosol in myeloid cells. Cell2007;129:1287. CrossRef

122. StoopEJ, BitterW, van der SarAM. Tubercle bacilli rely on a type VII army for pathogenicity. Trends Microbiol2012;20:477. CrossRef

123. Gey Van PittiusNC, et al.The ESAT‐6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram‐positive bacteria. Genome Biol2001;2:RESEARCH0044. CrossRef

124. AbdallahAM, et al.Mycobacterial secretion systems ESX‐1 and ESX‐5 play distinct roles in host cell death and inflammasome activation. J Immunol2011;187:4744. CrossRef

125. VandalOH, et al.A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med2008;14:849. CrossRef

126. NgVH, et al.Role of KatG catalase‐peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol2004;52:1291. CrossRef

127. DussurgetO, et al.Role of Mycobacterium tuberculosis copper‐zinc superoxide dismutase. Infect Immun2001;69:529. CrossRef

128. DivangahiM, et al.Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol2010;11:751. CrossRef

129. ShafianiS, et al.Pathogen‐specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med2010;207:1409. CrossRef

130. DivangahiM, et al.Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol2009;10:899. CrossRef

131. TufarielloJM, et al.Deletion of the Mycobacterium tuberculosis resuscitation‐promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect Immun2006;74:2985. CrossRef

132. RamageHR, ConnollyLE, CoxJS. Comprehensive functional analysis of Mycobacterium tuberculosis toxin‐antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet2009;5:e1000767. CrossRef

133. GringhuisSI, et al.Carbohydrate‐specific signaling through the DC‐SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV‐1 and Helicobacter pylori. Nat Immunol2009;10:1081. CrossRef

134. KangPB, et al.The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan‐mediated phagosome biogenesis. J Exp Med2005;202:987. CrossRef

135. MishraBB, et al.Mycobacterium tuberculosis protein ESAT‐6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol2010;12:1046. CrossRef

136. DivangahiM, et al.NOD2‐deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol2008;181:7157. CrossRef

137. CastilloEF, et al.Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci U S A2012;109:E3168. CrossRef

138. Klug‐MicuGM, et al.CD40 ligand and interferon‐gamma induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology2013;139:121. CrossRef

139. KleinnijenhuisJ, et al.Autophagy modulates the Mycobacterium tuberculosis‐induced cytokine response. Immunology2011;134:341. CrossRef

140. WalzlG, et al.Immunological biomarkers of tuberculosis. Nat Rev Immunol2011;11:343. CrossRef

141. WolfAJ, et al.Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med2008;205:105. CrossRef

142. JouanguyE, et al.Partial interferon‐gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette‐Guerin infection and a sibling with clinical tuberculosis. J Clin Invest1997;100:2658. CrossRef

143. LiuPT, et al.Toll‐like receptor triggering of a vitamin D‐mediated human antimicrobial response. Science2006;311:1770. CrossRef

144. EgenJG, et al.Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity2011;34:807. CrossRef

145. NossEH, et al.Toll‐like receptor 2‐dependent inhibition of macrophage class II MHC expression and antigen processing by 19‐kDa lipoprotein of Mycobacterium tuberculosis. J Immunol2001;167:910. CrossRef

146. KumarA, et al.Heme oxygenase‐1‐derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J Biol Chem2008;283:18032. CrossRef

147. ShermanDR, et al.Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha ‐crystallin. Proc Natl Acad Sci U S A2001;98:7534. CrossRef

148. GillWP, et al.A replication clock for Mycobacterium tuberculosis. Nat Med2009;15:211. CrossRef

149. DonoghueHD, HoltonJ. Intestinal tuberculosis. Curr Opin Infect Dis2009;22:490. CrossRef

150. NairKV, et al.Unusual presentations of duodenal tuberculosis. Am J Gastroenterol1991;86:756.

151. KimKM, et al.Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy. Am J Gastroenterol1998;93:606. CrossRef

152. LeeWK, et al.CT appearances of abdominal tuberculosis. Clin Radiol2012;67:596. CrossRef

153. von ReynCF, et al.Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. Int J Tuberc Lung Dis2011;15:1087. CrossRef

154. MudendaV, et al.Tuberculosis and tuberculosis/HIV/AIDS‐associated mortality in Africa:the urgent need to expand and invest in routine and research autopsies. J Infect Dis2012;205(Suppl 2):S340. CrossRef

155. ShahS, et al.Colonoscopic study of 50 patients with colonic tuberculosis. Gut1992;33:347. CrossRef

156. WaliaHS, et al.Unusual presentations of abdominal tuberculosis. Can J Surg1994;37:300.

157. HopewellPC, MiglioriGB, RaviglioneMC. Tuberculosis care and control. Bull World Health Organ2006;84:428. CrossRef

158. McNerneyR, et al.Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis2012;205(Suppl 2):S147. CrossRef

159. HillebrandDJ, et al.Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology1996;24:1408. CrossRef

160. BurgessLJ, SwanepoelCG, TaljaardJJ. The use of adenosine deaminase as adiagnostic tool for peritoneal tuberculosis. Tuberculosis (Edinb)2001;81:243. CrossRef

161. NagaMI, et al.Endoscopic diagnosis of colonic tuberculosis. Gastrointest Endosc2001;53:789. CrossRef

162. PulimoodAB, et al.Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol2011;17:433. CrossRef

163. DilauroS, Crum‐CianfloneNF. Ileitis: when it is not Crohn's disease. Curr Gastroenterol Rep2010;12:249. CrossRef

164. EnginG, BalkE. Imaging findings of intestinal tuberculosis. J Comput Assist Tomogr2005;29:37. CrossRef

165. LederRA, LowVH. Tuberculosis of the abdomen. Radiol Clin North Am1995;33:691.

166. AkhanO, PringotJ. Imaging of abdominal tuberculosis. Eur Radiol2002;12:312. CrossRef

167. MisiewiczJJ, ForbesA, PriceA, et al.Atlas of Clinical Gastroenterology, 2nd edn. London: Wolfe, 1994.

168. RasheedS, et al.Intra‐abdominal and gastrointestinal tuberculosis. Colorectal Dis2007;9:773. CrossRef

169. SuriS, GuptaS, SuriR. Computed tomography in abdominal tuberculosis. Br J Radiol1999;72:92. CrossRef

170. ViaLE, et al.Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2‐fluoro‐deoxy‐D‐glucose positron emission tomography and computed tomography. Antimicrob Agents Chemother2012;56:4391. CrossRef

171. HaHK, et al.Intestinal tuberculosis with abdominal complications: radiologic and pathologic features. Abdom Imaging1999;24:32. CrossRef

172. PulimoodAB, et al.Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol2005;20:688. CrossRef

173. WallisRS, et al.Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis2013;13:362. CrossRef

174. LawnSD, et al.Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point‐of‐care test. Lancet Infect Dis2013;13:349. CrossRef

175. LawnSD, NicolMP. Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol2011;6:1067. CrossRef

176. ChangK, et al.Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta‐analysis. J Infect2012;64:580. CrossRef

177. BinksM, et al.Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis2001;60:577. CrossRef

178. SteingartKR, et al.A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax2007;62:911.

179. HarariA, et al.Dominant TNF‐alpha+ Mycobacterium tuberculosis‐specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med2011;17:372. CrossRef

180. Abdool KarimSS, et al.Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med2011;365:1492. CrossRef

181. PawlowskiA, et al.Tuberculosis and HIV co‐infection. PLoS Pathog2012;8:e1002464. CrossRef

182. JanbazKH, et al.Tuberculosis: burning issues: multidrug resistance and HIV‐coinfection. Crit Rev Microbiol2012;38:267. CrossRef

183. FalzonD, et al.WHO guidelines for the programmatic management of drug‐resistant tuberculosis: 2011 update. Eur Respir J2011;38:516. CrossRef

184. MarshallJB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol1993;88:989.

185. YamamotoM, et al.Clinical characteristics and risk factors of non‐Candida fungaemia. BMC Infect Dis2013;13:247. CrossRef

186. AntachopoulosC, WalshTJ. Immunotherapy of Cryptococcus infections. Clin Microbiol Infect2012;18:126. CrossRef

187. KasugaT, et al.Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol2003;12:3383. CrossRef

188. KauffmanCA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev2007;20:115. CrossRef

189. McKinseyDS, et al.Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis1997;24:1195. CrossRef

190. DarlingST. The Morphology of the Parasite (Histoplasma Capsulatum) and the Lesions of Histoplasmosis, a Fatal Disease of Tropical America. J Exp Med1909;11:515. CrossRef

191. EdwardsLB, et al.An atlas of sensitivity to tuberculin, PPD‐B, and histoplasmin in the United States. Am Rev Respir Dis1969;99(Suppl 4):1.

192. SaidinejadM, BurnsMM, HarperMB. Disseminated histoplasmosis in a nonendemic area. Pediatr Infect Dis J2004;23:781. CrossRef

193. AssiM, et al.Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review. Diagn Microbiol Infect Dis2006;55:195. CrossRef

194. WheatLJ, et al.Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore)1990;69:361.

195. LampsLW, et al.The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol2000;113:64. CrossRef

196. KahiCJ, et al.Gastrointestinal histoplasmosis. Am J Gastroenterol2005;100:220. CrossRef

197. WheatLJ, KauffmanCA. Histoplasmosis. Infect Dis Clin North Am2003;17:1, vii. CrossRef

198. ColaiacovoR, et al.Disseminated histoplasmosis: a rare cause of multiple ulcers in the gastrointestinal tract. Endoscopy2011;43(Suppl 2 UCTN):E216. CrossRef

199. HeneghanSJ, et al.Intestinal perforation from gastrointestinal histoplasmosis in acquired immunodeficiency syndrome. Case report and review of the literature. Arch Surg1993;128:464. CrossRef

200. ZarrinparA, LinGY, LonerganJT. A rare cause of an ileocecal fistula in an AIDS patient. Gastrointestinal infection by Histoplasma capsulatum infection identified with internal transcribed spacer primer sets. Gastroenterology2013;144:697, 857‐8. CrossRef

201. SpinnerMA, PaulinHN, WesterCW. Duodenal Histoplasmosis Presenting with Upper Gastrointestinal Bleeding in an AIDS Patient. Case Rep Gastrointest Med2012;2012:515872. doi: 10.1155/2012/515872.

202. WheatLJ, et al.Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis2007;45:807. CrossRef

203. HechtFM, et al.Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol1997;16:100. CrossRef

204. WheatJ, et al.Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med1997;103:223. CrossRef

205. FreifeldA, et al.Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother2009;53:1648. CrossRef

206. LatgeJP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev1999;12:310.

207. DenningDW. Invasive aspergillosis. Clin Infect Dis1998;26:781, quiz 804‐5. CrossRef

208. Garnacho‐MonteroJ, Amaya‐VillarR. A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!Crit Care2006;10:132. CrossRef

209. KazanE, et al.A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect2011;17:588. CrossRef

210. PrescottRJ, HarrisM, BanerjeeSS. Fungal infections of the small and large intestine. J Clin Pathol1992;45:806. CrossRef

211. WalshTJ, et al.Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis2008;46:327. CrossRef

212. HerbrechtR, et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med2002;347:408. CrossRef

213. SchulzeJ, SonnenbornU. Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int2009;106:837.

214. FinkelJS, MitchellAP. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol2011;9:109. CrossRef

215. NaglikJR, ChallacombeSJ, HubeB. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev2003;67:400. table of contents. CrossRef

216. FrankCF, HostetterMK. Cleavage of E‐cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl Res2007;149:211. CrossRef

217. ThompsonDS, CarlislePL, KadoshD. Coevolution of morphology and virulence in Candida species. Eukaryot Cell2011;10:1173. CrossRef

218. PfallerMA, et al.National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis1998;31:327. CrossRef

219. GotoM, Al‐HasanMN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect2013;19:501. CrossRef

220. ArendrupMC, et al.Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect2013;19:E343. CrossRef

221. Finnish‐German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD‐type zinc‐finger domains. Nat Genet1997;17:399. CrossRef

222. van de VeerdonkFL, et al.STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med2011;365:54. CrossRef

223. LiuL, et al.Gain‐of‐function human STAT1 mutations impair IL‐17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med2011;208:1635. CrossRef

224. BassettiM, et al.Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE2011;6:e24198. CrossRef

225. ArendrupMC, et al.Semi‐national surveillance of fungaemia in Denmark 2004‐2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect2008;14:487. CrossRef

226. CornelyOA, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients. Clin Microbiol Infect2012;18(Suppl 7):19. CrossRef

227. Cuenca‐EstrellaM, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect2012;18(Suppl 7):9. CrossRef

228. HopeWW, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect2012;18(Suppl 7):38. CrossRef

229. LortholaryO, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect2012;18(Suppl 7):68. CrossRef

230. UllmannAJ, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect2012;18(Suppl 7):53. CrossRef

231. UllmannAJ, et al.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect2012;18(Suppl 7):1. CrossRef

232. Torres‐NarbonaM, et al.Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol2007;45:2051. CrossRef

233. BitarD, et al.Increasing incidence of zygomycosis (mucormycosis), France, 1997‐2006. Emerg Infect Dis2009;15:1395. CrossRef

234. RodenMM, et al.Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis2005;41:634. CrossRef

235. AntoniadouA. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect2009;15(Suppl 5):55. CrossRef

236. NolanRL, et al.Subacute disseminated mucormycosis in a diabetic male. Am J Med Sci1989;298:252. CrossRef

237. PetrikkosG, et al.Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis2012;54(Suppl 1):S23. CrossRef

238. SkiadaA, et al.Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect2011;17:1859. CrossRef

239. LyonDT, et al.Phycomycosis of the gastrointestinal tract. Am J Gastroenterol1979;72:379.